IP(DC) Podcast Por Ropes & Gray LLP arte de portada

IP(DC)

IP(DC)

De: Ropes & Gray LLP
Escúchala gratis

Acerca de esta escucha

A Ropes & Gray (RopesTalk) podcast series, focused on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C.© 2023 Política y Gobierno
Episodios
  • 5G for the C-Suite: Patent Hold-Up or Hold-Out?
    Feb 18 2020
    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C. In this episode of IP(DC), IP litigation partners Scott McKeown and Matt Rizzolo are joined by antitrust partner Chong Park to address Standard Essential Patents (SEPs) and their potential to complicate the roll-out of 5G-enabled products and infrastructure. The discussion explores risks for SEP licensors pending the FTC v. Qualcomm decision on Fair, Reasonable, and Non-discriminatory (FRAND) SEP licensing, refusal to deal, and compliance with Standard Setting Organization (SSO) obligations. On the implementer side, the discussion walks through patent hold-up and anti-competitive patent pooling practices. Matt and Scott also briefly preview 2020 legislative efforts in the patent space.
    Más Menos
    25 m
  • Inside Patent Reform Efforts, Anticipated Federal Circuit Appeals, and Patent Cases of the Upcoming Supreme Court Term
    Oct 2 2019
    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C. In this episode of IP(DC), appellate & Supreme Court partner Doug Hallward-Driemeier joins IP partners Scott McKeown and Matt Rizzolo to discuss the upcoming Supreme Court term as it relates to patent matters, current matters at the Federal Circuit, and ongoing legislative efforts in Congress to reform 35 U.S.C. Section 101 – patent subject matter eligibility.
    Más Menos
    45 m
  • Drug Prices, Political Pressures & Patents
    Aug 20 2019
    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C. The Trump Administration has targeted U.S. drug prices through a number of as yet unsuccessful cost control schemes—with the promise of more to come. At the same time, Congress is looking to restore patenting options for some technical areas such as medical diagnostics, while combating patent “ever-greening” for blockbuster drugs and treatments. Given this storm of legal issues, this IP(DC) podcast tackles the Administration’s confusing efforts to reign in drug pricing to date, while touching upon competing policies at play on the patent side of the business. In this episode, health care partner Tom Bulleit joins IP partners Scott McKeown and Matt Rizzolo.
    Más Menos
    19 m
Todavía no hay opiniones